Abeona Therapeutics Inc.
ABEO
$4.95
$0.275.77%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 97.72M | 109.70M | 122.71M | 62.34M | 52.23M |
Total Receivables | 1.65M | 1.61M | 1.64M | 2.23M | 2.44M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.14M | 1.01M | 1.22M | 1.81M | 729.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 338.00K | 338.00K | 338.00K | 338.00K | 338.00K |
Total Current Assets | 100.85M | 112.66M | 125.90M | 66.73M | 55.74M |
|
|||||
Total Current Assets | 100.85M | 112.66M | 125.90M | 66.73M | 55.74M |
Net Property, Plant & Equipment | 7.98M | 7.85M | 8.00M | 7.99M | 7.99M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 96.00K | 88.00K | 100.00K | 114.00K | 277.00K |
Total Assets | 108.93M | 120.59M | 134.00M | 74.83M | 64.00M |
|
|||||
Total Accounts Payable | 3.44M | 2.79M | 3.10M | 3.36M | 1.86M |
Total Accrued Expenses | 6.33M | 5.21M | 4.92M | 2.79M | 5.99M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.75M | 5.50M | 4.01M | 1.04M | 998.00K |
Total Finance Division Other Current Liabilities | 64.00K | 4.92M | 4.81M | 4.69M | 4.58M |
Total Other Current Liabilities | 64.00K | 4.92M | 4.81M | 4.69M | 4.58M |
Total Current Liabilities | 16.59M | 18.42M | 16.84M | 11.89M | 13.42M |
|
|||||
Total Current Liabilities | 16.59M | 18.42M | 16.84M | 11.89M | 13.42M |
Long-Term Debt | 13.04M | 14.21M | 16.13M | 18.08M | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 3.26M | 3.40M | 3.02M | 4.05M | 4.40M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 32.01M | 38.79M | 24.77M | 49.70M | 31.35M |
Total Liabilities | 64.90M | 74.82M | 60.76M | 83.71M | 49.18M |
|
|||||
Common Stock & APIC | 857.28M | 849.82M | 847.07M | 772.41M | 764.42M |
Retained Earnings | -813.26M | -803.97M | -773.70M | -781.10M | -749.52M |
Treasury Stock & Other | 8.00K | -84.00K | -134.00K | -184.00K | -66.00K |
Total Common Equity | 44.03M | 45.77M | 73.24M | -8.88M | 14.83M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 44.03M | 45.77M | 73.24M | -8.88M | 14.83M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 44.03M | 45.77M | 73.24M | -8.88M | 14.83M |
|